Suggested by the presence of at least one clinical and one laboratory feature.
Treatment: Antiphospholipid Syndrome
|
For a more detailed discussion, see Hahn BH: Systemic Lupus Erythematosus, Chap. 378, p. 2124; Shah A, St. Clair EW: Rheumatoid Arthritis, Chap. 380, p. 2136; Varga J: Systemic Sclerosis (Scleroderma) and Related Disorders, Chap. 382, p. 2154; Moutsopoulos HM, Tzioufas AG: Sjögren's Syndrome, Chap. 383, p. 2166; Moutsopoulos HM, Vlachoyiannopoulos PG: Antiphospholipid Syndrome, Chap. 379, p. 2134, in HPIM-19. |
Section 12. Allergy, Clinical Immunology, and Rheumatology